Overview
Chil Oh practices in Seoul, Republic of Korea. Oh is rated as a Distinguished expert by MediFind in the treatment of Trichorhinophalangeal Syndrome Type 1 (TRPS1). Their top areas of expertise are Trichorhinophalangeal Syndrome Type 1 (TRPS1), Punctate Porokeratosis, Seborrheic Keratosis, and Autosomal Recessive Hypotrichosis.
Their clinical research consists of co-authoring 21 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Trichorhinophalangeal Syndrome Type 1 (TRPS1).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Trichorhinophalangeal Syndrome Type 1 (TRPS1)
- Experienced
- Actinic KeratosisOh isExperienced. Learn about Actinic Keratosis.
- Autosomal Recessive Hypotrichosis
- Hereditary Multiple Osteochondromas
- Punctate PorokeratosisOh isExperienced. Learn about Punctate Porokeratosis.
- Seborrheic KeratosisOh isExperienced. Learn about Seborrheic Keratosis.